| Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors JE Eckel-Passow, DH Lachance, AM Molinaro, KM Walsh, PA Decker, ... New England Journal of Medicine 372 (26), 2499-2508, 2015 | 2045 | 2015 |
| Prediction error estimation: a comparison of resampling methods AM Molinaro, R Simon, RM Pfeiffer Bioinformatics 21 (15), 3301-3307, 2005 | 1528 | 2005 |
| Survival ensembles T Hothorn, P Bühlmann, S Dudoit, A Molinaro, MJ Van Der Laan Biostatistics 7 (3), 355-373, 2006 | 957 | 2006 |
| Genetic and molecular epidemiology of adult diffuse glioma AM Molinaro, JW Taylor, JK Wiencke, MR Wrensch Nature Reviews Neurology 15 (7), 405-417, 2019 | 568 | 2019 |
| Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma YL Hu, M DeLay, A Jahangiri, AM Molinaro, SD Rose, WS Carbonell, ... Cancer research 72 (7), 1773-1783, 2012 | 530 | 2012 |
| Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study N Butowski, H Colman, JF De Groot, AM Omuro, L Nayak, PY Wen, ... Neuro-oncology 18 (4), 557-564, 2015 | 527 | 2015 |
| Survival and low-grade glioma: the emergence of genetic information EB Claus, KM Walsh, JK Wiencke, AM Molinaro, JL Wiemels, ... Neurosurgical focus 38 (1), E6, 2015 | 459 | 2015 |
| Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed … AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ... JAMA oncology 6 (4), 495-503, 2020 | 443 | 2020 |
| Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period SL Hervey-Jumper, J Li, D Lau, AM Molinaro, DW Perry, L Meng, ... Journal of neurosurgery 123 (2), 325-339, 2015 | 437 | 2015 |
| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 417 | 2019 |
| Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis K Kerlikowske, AM Molinaro, ML Gauthier, HK Berman, F Waldman, ... Journal of the National Cancer Institute 102 (9), 627-637, 2010 | 417 | 2010 |
| Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors PK Sneed, J Mendez, JGM Vemer-van den Hoek, ZA Seymour, L Ma, ... Journal of neurosurgery 123 (2), 373-386, 2015 | 322 | 2015 |
| Characteristics Associated With Recurrence Among Women With Ductal Carcinoma In Situ Treated by Lumpectomy K Kerlikowske, A Molinaro, I Cha, BM Ljung, VL Ernster, K Stewart, ... Journal of the National Cancer Institute 95 (22), 1692-1702, 2003 | 313 | 2003 |
| Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT M Pekmezci, T Rice, AM Molinaro, KM Walsh, PA Decker, H Hansen, ... Acta neuropathologica 133, 1001-1016, 2017 | 307 | 2017 |
| DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors T Mazor, A Pankov, BE Johnson, C Hong, EG Hamilton, RJA Bell, ... Cancer cell 28 (3), 307-317, 2015 | 266 | 2015 |
| Toward precision medicine in glioblastoma: the promise and the challenges MD Prados, SA Byron, NL Tran, JJ Phillips, AM Molinaro, KL Ligon, ... Neuro-oncology 17 (8), 1051-1063, 2015 | 247 | 2015 |
| Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging RF Barajas Jr, JJ Phillips, R Parvataneni, A Molinaro, E Essock-Burns, ... Neuro-oncology 14 (7), 942-954, 2012 | 228 | 2012 |
| Genome-wide screen of promoter methylation identifies novel markers in melanoma Y Koga, M Pelizzola, E Cheng, M Krauthammer, M Sznol, S Ariyan, ... Genome research 19 (8), 1462-1470, 2009 | 222 | 2009 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 219 | 2022 |
| High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer S Ghosh, CAW Sullivan, MP Zerkowski, AM Molinaro, DL Rimm, RL Camp, ... Human pathology 39 (12), 1835-1843, 2008 | 218 | 2008 |
Joanna PhillipsUCSFVerified email at ucsf.edu
